$15.82
-0.11 (-0.66%)
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+220.4% upside
Low Target
$44.22
Average Target
$50.69
High Target
$73.56
Current Price
$15.82
Current
$15.82
$15.82
Target
$50.69
$50.69
$44.22
$50.69 avg
$73.56
Scenario Analysis
Bear Case
$44.22
179.5%
Low target
Base Case
$50.69
+220.4%
Avg target
Bull Case
$73.56
+365.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$18.89
-16.3% from high
52-Week Low
$4.96
+219.3% from low
Target vs 52W High
$50.69
+168.3% vs high
Next Earnings Report
Nov 10, 2026
3d
until earnings
EPS Est: $-0.26
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 35 | 86% | $369.21 | -45.5% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -30.1% |
| A | Buy | 29 | 72% | $64.69 | -62.3% |
| WAT | Buy | 30 | 70% | $189.60 | -58.2% |
| IQV | Strong Buy | 27 | 85% | $82.96 | -68.7% |
| ILMN | Buy | 28 | 57% | $169.36 | -18.6% |
| MTD | Hold | 19 | 47% | $170.43 | -89.8% |
| WST | Strong Buy | 22 | 95% | $136.24 | -65.3% |